- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02713425
Pediatric Anxiety Intervention With an Entertaining Video Game: Feasibility Study
August 13, 2019 updated by: Stephen Whiteside, Mayo Clinic
This research study aims to test the feasibility and effectiveness of using an entertaining video game as an addition to traditional therapy for the treatment of anxiety disorders in youth, particularly those youth who may have limited access to mental health treatment in the traditional clinical setting.
Study Overview
Detailed Description
The purpose of this research is to learn whether or not youth with social anxiety find a therapeutic video game engaging and useful.
Children between the ages of 7 & 17 who have been diagnosed with a social anxiety disorder will be invited to participate in this study.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 17 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 7 to 17
Primary diagnosis of:
- social phobia,
- separation anxiety disorder
- A parent or other primary care giver available to participate with the child in all assessment and treatment activities
- Estimated average intelligence
- English speaking
- Received les than 3 treatment sessions for social anxiety disorder
Exclusion Criteria:
History of and/or current diagnosis of:
- psychosis,
- autism,
- bipolar disorder,
- mental retardation,
- oppositional defiant disorder,
- PTSD,
- selective mutism, or
- major depressive disorder
- Current suicidality or recent suicidal behavior
- Parent to be involved in study who is unable to adequately participate due to intellectual or psychiatric difficulties
- Starting or changing the dosage of a psychiatric medication in the last two months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Single Arm - Entertaining Video Game
The children in this study will have a single visit.
During this visit they will be introduced to the game.
The child will then interact with the game and after they have finished, they will be asked questions about their experience with the game.
Parents will observe and provide their own feedback about the game.
|
Children between 7 & 17 with a social anxiety disorder will be invited to participate in this study.
They will attend a single visit.
During the visit they will use the therapeutic game.
They will be monitored while using the game.
After the completion, they will be asked questions regarding their experience with this therapeutic game.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Change From Baseline in Subjective Units of Distress Scale (SUDS) at End of Session
Time Frame: approximately 10 minutes
|
Subjective Units of Distress Scale (SUDs) - of 0 to 10 ratings, where 0 indicates that they feel no anxiety whatsoever and 10 indicates that they are experiencing maximum distress.
The child interacts with the game for up to 30 minutes.
The interviewer observes and records the child's interaction with the game.
The child then has an opportunity to perform a real life exposure.
For the remainder of the time, the interviewer will interview the child about his/her experience with the game.
They will also get feedback from the parent.
|
approximately 10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Average Child Rating of Preferring the Game to Not Having the Game
Time Frame: approximately 30 minutes
|
rating of 0(without) to 10 (with) preference to use game
|
approximately 30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stephen Whiteside, Ph.D., L.P., Mayo Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2016
Primary Completion (Actual)
June 15, 2017
Study Completion (Actual)
July 15, 2017
Study Registration Dates
First Submitted
March 15, 2016
First Submitted That Met QC Criteria
March 17, 2016
First Posted (Estimate)
March 18, 2016
Study Record Updates
Last Update Posted (Actual)
September 4, 2019
Last Update Submitted That Met QC Criteria
August 13, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-000162
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiRecruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Loyola UniversityCompletedAnxiety | Anxiety State | Procedural AnxietyUnited States
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
Dr. Nazanin AlaviActive, not recruitingGeneralized Anxiety Disorder | AnxietyCanada
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
-
Loma Linda UniversityCompletedParental/Caregiver Anxiety | Child's AnxietyUnited States
Clinical Trials on Entertaining Video Game
-
San Francisco Veterans Affairs Medical CenterVA Office of Research and DevelopmentCompletedTBI (Traumatic Brain Injury)United States
-
University of Wisconsin, MadisonBrain & Behavior Research FoundationCompleted
-
Brigham Young UniversityCompleted
-
Yale UniversityCompleted
-
Université Blaise Pascal, Clermont-FerrandWithdrawnPassive Video Games (PVG) | Active Video Games (AVG) | Exercise (EX)France
-
Anne KloosCompletedHuntington's DiseaseUnited States
-
Boston University Charles River CampusCarnegie Mellon UniversityWithdrawnAutism Spectrum Disorder | AutismUnited States
-
Bard CollegeUniversity of Texas at AustinCompleted
-
Massachusetts Eye and Ear InfirmaryNot yet recruitingHigh-Frequency Hearing Loss